KERALA AYURVEDA
Back to Balance Sheet
|
KERALA AYURVEDA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹65 Cr | ₹55 Cr | ₹42 Cr | ₹67 Cr | ₹63 Cr |
What is the latest Total Non-Current Liabilities ratio of KERALA AYURVEDA ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹65 Cr |
Mar2023 | ₹55 Cr |
Mar2022 | ₹42 Cr |
Mar2021 | ₹67 Cr |
Mar2020 | ₹63 Cr |
How is Total Non-Current Liabilities of KERALA AYURVEDA Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹65 Cr | 19.29 | |
Mar2023 | ₹55 Cr | 30.65 | |
Mar2022 | ₹42 Cr | -37.36 | |
Mar2021 | ₹67 Cr | 6.55 | |
Mar2020 | ₹63 Cr | - |
Compare Total Non-Current Liabilities of peers of KERALA AYURVEDA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KERALA AYURVEDA | ₹575.9 Cr | 4.4% | -4.5% | 57.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹386,197.0 Cr | 0.9% | -0.2% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,634.0 Cr | 0.1% | 0.4% | 16.6% | Stock Analytics | |
CIPLA | ₹126,082.0 Cr | 0.5% | 3.8% | -3.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,167.0 Cr | NA | -0.9% | 4.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,783.0 Cr | 2.8% | 6.9% | -2% | Stock Analytics |
KERALA AYURVEDA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KERALA AYURVEDA | 4.4% |
-4.5% |
57.1% |
SENSEX | 1% |
2.1% |
0.5% |
You may also like the below Video Courses